Genmab AS (Denmark) Market Value

GMAB Stock  DKK 2,043  2.00  0.1%   
Genmab AS's market value is the price at which a share of Genmab AS stock trades on a public exchange. It measures the collective expectations of Genmab AS investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Genmab AS and determine expected loss or profit from investing in Genmab AS over a given investment horizon.
Check out Genmab AS Correlation, Genmab AS Volatility and Genmab AS Alpha and Beta module to complement your research on Genmab AS.
To learn how to invest in Genmab Stock, please use our How to Invest in Genmab AS guide.
Symbol

Please note, there is a significant difference between Genmab AS's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genmab AS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genmab AS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Genmab AS 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Genmab AS's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Genmab AS.
0.00
02/17/2024
No Change 0.00  0.0 
In 31 days
03/18/2024
0.00
If you would invest  0.00  in Genmab AS on February 17, 2024 and sell it all today you would earn a total of 0.00 from holding Genmab AS or generate 0.0% return on investment in Genmab AS over 30 days. Genmab AS is related to or competes with Nordinvestments, Hvidbjerg Bank, Laan Spar, Skjern Bank, PF BankNordik, and NTG Nordic. Genmab AS develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark More

Genmab AS Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Genmab AS's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Genmab AS upside and downside potential and time the market with a certain degree of confidence.

Genmab AS Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Genmab AS's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Genmab AS's standard deviation. In reality, there are many statistical measures that can use Genmab AS historical prices to predict the future Genmab AS's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Genmab AS's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Genmab AS in the context of predictive analytics.
Hype
Prediction
LowEstimatedHigh
2,0412,0432,045
Details
Intrinsic
Valuation
LowRealHigh
1,7721,7742,247
Details
Naive
Forecast
LowNextHigh
2,1102,1122,114
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1,9922,0742,156
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Genmab AS. Your research has to be compared to or analyzed against Genmab AS's peers to derive any actionable benefits. When done correctly, Genmab AS's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Genmab AS.

Genmab AS Backtested Returns

Genmab AS holds Efficiency (Sharpe) Ratio of -0.0255, which attests that the entity had -0.0255% return per unit of risk over the last 3 months. Our standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Genmab AS exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its stock price that cannot be diversified away. Please check out Genmab AS's Market Risk Adjusted Performance of (0), risk adjusted performance of 0.0082, and Downside Deviation of 2.08 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.52, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Genmab AS returns are expected to increase less than the market. However, during the bear market, the loss on holding Genmab AS will be expected to be smaller as well. Even though it is essential to pay attention to Genmab AS current price history, it is always good to be careful when utilizing equity current price movements. Genmab AS has an expected return of -0.0488%. Please make sure to check out Genmab AS standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio to decide if Genmab AS performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.49  

Modest reverse predictability

Genmab AS has modest reverse predictability. Overlapping area represents the amount of predictability between Genmab AS time series from 17th of February 2024 to 3rd of March 2024 and 3rd of March 2024 to 18th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Genmab AS price movement. The serial correlation of -0.49 indicates that about 49.0% of current Genmab AS price fluctuation can be explain by its past prices.
Correlation Coefficient-0.49
Spearman Rank Test-0.45
Residual Average0.0
Price Variance4461.19

Genmab AS lagged returns against current returns

Autocorrelation, which is Genmab AS stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Genmab AS's stock expected returns. We can calculate the autocorrelation of Genmab AS returns to help us make a trade decision. For example, suppose you find that Genmab AS stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Genmab AS regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Genmab AS stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Genmab AS stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Genmab AS stock over time.
   Current vs Lagged Prices   
       Timeline  

Genmab AS Lagged Returns

When evaluating Genmab AS's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Genmab AS stock have on its future price. Genmab AS autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Genmab AS autocorrelation shows the relationship between Genmab AS stock current value and its past values and can show if there is a momentum factor associated with investing in Genmab AS.
   Regressed Prices   
       Timeline  

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Genmab AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genmab AS's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genmab As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genmab As Stock:
Check out Genmab AS Correlation, Genmab AS Volatility and Genmab AS Alpha and Beta module to complement your research on Genmab AS.
To learn how to invest in Genmab Stock, please use our How to Invest in Genmab AS guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Genmab Stock analysis

When running Genmab AS's price analysis, check to measure Genmab AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab AS is operating at the current time. Most of Genmab AS's value examination focuses on studying past and present price action to predict the probability of Genmab AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab AS's price. Additionally, you may evaluate how the addition of Genmab AS to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Genmab AS technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Genmab AS technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Genmab AS trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...